Javascript must be enabled to continue!
e0348 The Effects of valsartan on angiotensin ii type 1 and type 2 receptor in isolated reperfused ischaemic rat hearts
View through CrossRef
Object
To determine the effects of Angiotensin II Type 1 receptor blockade valsartan on AT1 and AT2 receptor during ischaemia reperfusion.
Methods
The hearts of 24 SD rats were isolated, linked to Langedorff perfusion apparatus, and randomly divided into 3 equal groups: control group, perfused with modified Kreb-Henseleit (K-H) buffer for 110 min; ischaemia/reperfusion (I/R) group, perfused with K-H buffer for 20 min, exposed to ischaemia for 30 min, and then reperfused with K-H buffer for 60 min; valsartan group, perfused with K-H buffer with valsartan for 20 min, exposed to ischaemia for 30 min, and then reperfused with K-H with valsartan for 60 min. The left ventricular (LV) function including maximal uprising velocity of left ventricular pressure (+dp/dtmax) and maximal decreasing velocity of left ventricular pressure (–dP/dtmax) were monitor. The coronary effluent were measured 20 min after the stabilisation of perfusion, and 20, 40, and 60 min after reperfusion. After the stop of reperfusion, the structure were observed using electron microscope. The AT1 and AT2 receptor mRNA express were examined by Northern blot. The AT1 and AT2 receptor protein expression were examed by Northern blot.
Results
Compared with control, I/R impaired left ventricular systolic and diastolic function (+dp/dtmax 1892±231 mm Hg.s−1 vs 836±223 mm Hg.s−1; −dp/dtmax --1175±223 mm Hg.s−1 vs −613±224 mm Hg.s−1, all p<0.01), decreased coronary effluent (5.9±0.8 ml.min−1 vs 3.3±0.5 ml.min−1, p<0.01) damaged the structure. Increased AT1 receptor mRNA and protein. Decreased AT2 receptor mRNA and protein express. valsartan improved left ventricular function (+dp/dtmax 1337±226 mm Hg.s−1; −dp/dtmax −871±208 mm Hg.s−1, compared with I/R group, all p<0.01), increased coronary effluent (4.2±∆0.7 ml.min−1, compared with I/R group, p<0.01). Increased AT2 receptor mRNA and protein express with no changes in AT1 receptor mRNA and protein express.
Conclusions
AT1 receptor blockade valsartan induces short-term cardioprotection associated with enhanced AT2 receptor expression during myocardial ischaemia reperfusion.
Title: e0348 The Effects of valsartan on angiotensin ii type 1 and type 2 receptor in isolated reperfused ischaemic rat hearts
Description:
Object
To determine the effects of Angiotensin II Type 1 receptor blockade valsartan on AT1 and AT2 receptor during ischaemia reperfusion.
Methods
The hearts of 24 SD rats were isolated, linked to Langedorff perfusion apparatus, and randomly divided into 3 equal groups: control group, perfused with modified Kreb-Henseleit (K-H) buffer for 110 min; ischaemia/reperfusion (I/R) group, perfused with K-H buffer for 20 min, exposed to ischaemia for 30 min, and then reperfused with K-H buffer for 60 min; valsartan group, perfused with K-H buffer with valsartan for 20 min, exposed to ischaemia for 30 min, and then reperfused with K-H with valsartan for 60 min.
The left ventricular (LV) function including maximal uprising velocity of left ventricular pressure (+dp/dtmax) and maximal decreasing velocity of left ventricular pressure (–dP/dtmax) were monitor.
The coronary effluent were measured 20 min after the stabilisation of perfusion, and 20, 40, and 60 min after reperfusion.
After the stop of reperfusion, the structure were observed using electron microscope.
The AT1 and AT2 receptor mRNA express were examined by Northern blot.
The AT1 and AT2 receptor protein expression were examed by Northern blot.
Results
Compared with control, I/R impaired left ventricular systolic and diastolic function (+dp/dtmax 1892±231 mm Hg.
s−1 vs 836±223 mm Hg.
s−1; −dp/dtmax --1175±223 mm Hg.
s−1 vs −613±224 mm Hg.
s−1, all p<0.
01), decreased coronary effluent (5.
9±0.
8 ml.
min−1 vs 3.
3±0.
5 ml.
min−1, p<0.
01) damaged the structure.
Increased AT1 receptor mRNA and protein.
Decreased AT2 receptor mRNA and protein express.
valsartan improved left ventricular function (+dp/dtmax 1337±226 mm Hg.
s−1; −dp/dtmax −871±208 mm Hg.
s−1, compared with I/R group, all p<0.
01), increased coronary effluent (4.
2±∆0.
7 ml.
min−1, compared with I/R group, p<0.
01).
Increased AT2 receptor mRNA and protein express with no changes in AT1 receptor mRNA and protein express.
Conclusions
AT1 receptor blockade valsartan induces short-term cardioprotection associated with enhanced AT2 receptor expression during myocardial ischaemia reperfusion.
Related Results
Efficacy and safety of vericiguat in patients with HFrEF treated with sacubitril/valsartan: results from the VICTORIA trial
Efficacy and safety of vericiguat in patients with HFrEF treated with sacubitril/valsartan: results from the VICTORIA trial
Abstract
Background
In the VICTORIA trial (n=5050) the reduction in the primary composite endpoint of cardiovascular death (CVD)...
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
1.Effect of chronic haloperidol treatment on D‐2 receptors labelled by (3H)‐spiperone in homogenates of rat corpus striatum. A. L. Gundlach, D. J. de Vries and P. M. Beart2.The eff...
Comparative and Combinatorial Effects of Resveratrol and Sacubitril/Valsartan alongside Valsartan on Cardiac Remodeling and Dysfunction in MI-Induced Rats
Comparative and Combinatorial Effects of Resveratrol and Sacubitril/Valsartan alongside Valsartan on Cardiac Remodeling and Dysfunction in MI-Induced Rats
The development and progression of heart failure (HF) due to myocardial infarction (MI) is a major concern even with current optimal therapy. Resveratrol is a plant polyphenol with...
Pengaruh Valsartan Terhadap Fibrosis Ginjal pada Obstruksi Ureter
Pengaruh Valsartan Terhadap Fibrosis Ginjal pada Obstruksi Ureter
AbstrakPendahuluan : Obstruksi ureter merupakan kondisi yang dapat terjadi pada setiap usia dengan levelbervariasi dengan efek terburuk berupa gagal ginjal permanen. Terdapat berba...
Angiotensin Type 2 Receptor Mediates Valsartan-Induced Hypotension in Conscious Rats
Angiotensin Type 2 Receptor Mediates Valsartan-Induced Hypotension in Conscious Rats
Abstract
—Inhibition of the renin-angiotensin system is associated with vasodilation and reduction in blood pressure. We hypothesized that angiotensin type 1 (AT
...
Runahead threads
Runahead threads
Los temas de investigación sobre multithreading han ganado mucho interés en la arquitectura de computadores con la aparición de procesadores multihilo y multinucleo. Los procesador...
Kajian Literatur Profil Farmakokinetika Sacubitril-Valsartan Pada Subjek Sehat dan Gagal Jantung
Kajian Literatur Profil Farmakokinetika Sacubitril-Valsartan Pada Subjek Sehat dan Gagal Jantung
Abstract. Sacubitril-Valsartan is a first-class therapeutic agent for ARNI (Angiotensin Receptor-Neprilysin Inhibitor) which can reduce blood pressure and reduce mortality and morb...
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
14th Annual Meeting, December 1980, Canberra1. Effect of dexamethasone on pineal β‐adrenoceptors. C. A. Maxwell, A. Foldes, N. T. Hinks and R. M. Hoskinson2. A clinicopathological ...

